APA (7th ed.) Citation

Anthony Ku, Misaki Kondo, Zhongli Cai, Jalna Meens, Min Rong Li, Laurie Ailles, & Raymond M. Reilly. (2021). Dose predictions for [177Lu]Lu-DOTA-panitumumab F(ab')2 in NRG mice with HNSCC patient-derived tumour xenografts based on [64Cu]Cu-DOTA-panitumumab F(ab')2 - implications for a PET theranostic strategy. SpringerOpen.

Chicago Style (17th ed.) Citation

Anthony Ku, Misaki Kondo, Zhongli Cai, Jalna Meens, Min Rong Li, Laurie Ailles, and Raymond M. Reilly. Dose Predictions for [177Lu]Lu-DOTA-panitumumab F(ab')2 in NRG Mice with HNSCC Patient-derived Tumour Xenografts Based on [64Cu]Cu-DOTA-panitumumab F(ab')2 - Implications for a PET Theranostic Strategy. SpringerOpen, 2021.

MLA (9th ed.) Citation

Anthony Ku, et al. Dose Predictions for [177Lu]Lu-DOTA-panitumumab F(ab')2 in NRG Mice with HNSCC Patient-derived Tumour Xenografts Based on [64Cu]Cu-DOTA-panitumumab F(ab')2 - Implications for a PET Theranostic Strategy. SpringerOpen, 2021.